Real-time enrollment status for this drug resistant epilepsy clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:04 AM UTC
| NCT Number | NCT03868293 |
| Recruiting Status | Recruiting |
| Condition | Drug Resistant Epilepsy |
| Phase | NA |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Brigham and Women's Hospital |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of September 1, 2026: Clinical trial NCT03868293 is currently recruiting participants. This na study for drug resistant epilepsy is actively seeking new participants at 1 location across the United States. The study is sponsored by Brigham and Women's Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03868293 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03868293 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.